Unknown

Dataset Information

0

VX-984 is a selective inhibitor of non-homologous end joining, with possible preferential activity in transformed cells.


ABSTRACT: Purpose:DNA double-strand breaks (DSBs) can be repaired by non-homologous end joining (NHEJ) or homologous recombination (HR). We demonstrate the selectivity of VX-984, a DNA-PK inhibitor, using assays not previously reported. Experimental Design:The class switch recombination assay (CSR) in primary B cells was used to measure efficiency of NHEJ. A cellular reporter assay (U2OS EJ-DR) was used to assess the efficiency of HR and NHEJ in cells treated with VX-984. Immunofluorescence assays (IF) evaluated ?-H2AX foci for DSB repair kinetics in human astrocytes and T98G glioma cells. Western blotting was used to evaluate phosphorylation of DNA-PKcs substrates. Results:We found a dose-dependent reduction in CSR efficiency with VX-984, and through the EJ-DR assay, dramatic dose-dependent increases in HR and mNHEJ. Immunofluorescence assays showed an inability of malignant cells to resolve ?-H2AX foci in the presence of VX-984. Radiation-induced phosphorylation of DNA-PK substrates was further reduced by treatment with VX-984. Conclusions:VX-984 efficiently inhibits NHEJ, resulting in compensatory increases in alternative repair pathways, increases DSBs, and appears to affect transformed cells preferentially.

SUBMITTER: Khan AJ 

PROVIDER: S-EPMC5995231 | biostudies-literature | 2018 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

VX-984 is a selective inhibitor of non-homologous end joining, with possible preferential activity in transformed cells.

Khan Atif J AJ   Misenko Sarah M SM   Thandoni Aditya A   Schiff Devora D   Jhawar Sachin R SR   Bunting Samuel F SF   Haffty Bruce G BG  

Oncotarget 20180525 40


<h4>Purpose</h4>DNA double-strand breaks (DSBs) can be repaired by non-homologous end joining (NHEJ) or homologous recombination (HR). We demonstrate the selectivity of VX-984, a DNA-PK inhibitor, using assays not previously reported.<h4>Experimental design</h4>The class switch recombination assay (CSR) in primary B cells was used to measure efficiency of NHEJ. A cellular reporter assay (U2OS EJ-DR) was used to assess the efficiency of HR and NHEJ in cells treated with VX-984. Immunofluorescence  ...[more]

Similar Datasets

| S-EPMC6508539 | biostudies-literature
| S-EPMC4745757 | biostudies-literature
| S-EPMC4037875 | biostudies-literature
2008-06-14 | E-GEOD-6178 | biostudies-arrayexpress
| S-EPMC6297349 | biostudies-literature
| S-EPMC2776107 | biostudies-literature
| S-EPMC4914968 | biostudies-literature
| S-EPMC5539760 | biostudies-literature
| S-EPMC4244233 | biostudies-literature
| S-EPMC4408008 | biostudies-literature